RIA
IGC icon

Realta Investment Advisors’s IGC Pharma IGC Stock Holding History

Realta Investment Advisors’s Portfolio IGC Stock Details IGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-425
Closed -$1K – 1696
2019
Q2 		$1K Buy
+425
New +$600 ﹤0.01% 1627

Other funds holding IGC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CFA
Carroll Financial Associates Charlotte, North Carolina $1.88B AUM 20.52% 1-Year Est. Return
DP
Dearborn Partners Chicago, Illinois $1.85B AUM 6.59% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Realta Investment Advisors's IGC Position: Q3 2019 in Review

Realta Investment Advisors sold out of IGC Pharma (IGC) in Q3 2019, closing a stake of 425 shares — an estimated $1K sold.

Realta Investment Advisors first reported a position in IGC in Q2 2019 and held it in 1 quarter. The position peaked at $1K in Q2 2019. 26 funds tracked by Wall St. Rank hold IGC as of Q3 2019.

  • Realta Investment Advisors reported no remaining IGC Pharma position as of Q3 2019 after selling out during the quarter.
  • Realta Investment Advisors sold 425 IGC Pharma shares in Q3 2019, an estimated $1K.
  • Realta Investment Advisors first reported a position in IGC Pharma in Q2 2019 and held it in 1 quarter.
  • Realta Investment Advisors's IGC Pharma position peaked at $1K in Q2 2019.
  • 26 funds tracked by Wall St. Rank held IGC Pharma as of Q3 2019.

Based on Realta Investment Advisors's 13F filing for Q3 2019, filed 18 Oct 2019.